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DESCRIPTION
A 16-year-old girl presented with fluctuating diplo-
pia, ptosis of the left eye and an internuclear oph-
thalmoplegia (INO; video 1), which resolved after
administration of neostigmine. Antiacetylcholine
receptor antibodies were present in the serum:
0.34 nmol/L (normal range 0–0.25 nmol/L). These
findings led to the diagnosis of ocular myasthenia.
INO is mostly seen with lesions of the medial
longitudinal fasciculus in the dorsomedial brain-
stem tegmentum of either the pons or the mid-
brain, causing adduction weakness of the ipsilateral
eye and a contralateral abduction nystagmus. The
underlying mechanisms causing abduction nystag-
mus are not fully understood. Probably, it reflects
an adaptive process that helps to overcome the
adduction weakness of the opposite eye.1 This is
consistent with Hering’s law of equal innervation,
which states that increased innervation to a weak
muscle in one eye is accompanied by a commensur-
ate increase in innervation to the yoke muscle in
the other eye.
In myasthenia gravis (MG), extraocular muscle
weakness can cause the same oculomotor pattern as
in INO.2 However, in such cases there is no lesion
in the central nervous system and therefore it has
been referred to as pseudo-INO. In MG, there is
intermittent block of neuromuscular conduction to
extraocular muscles, which causes muscle weakness.
Although the adduction weakness has a different
cause as in INO, the assumed pathogenetic mech-
anism of the abduction nystagmus in pseudo-INO
is the same.3 Pseudo-INO can also be a clinical
manifestation of Guillain-Barré syndrome (GBS) or
the Miller-Fisher variant of GBS.3
The symptoms in our patient completely
resolved rapidly after treatment with low doses of
pyridostigmine (30 mg four times a day).
Learning points
▸ In any patient with an internuclear
ophthalmoplegia (INO) which can not be
explained by a lesion in the brainstem,
consider pseudo-INO.
▸ In the case of pseudo-INO, it is important to
perform additional tests on diagnosing
myasthenia gravis.
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Video 1 Nystagmus of the abducting left eye and
impaired adduction of the right eye, representing a
pseudo-internuclear ophthalmoplegia (pseudo-INO) in a
patient with ocular myasthenia gravis. Also note the
slight ptosis of the left eye.
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